NCT01047397View on ClinicalTrials.gov

Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia

PHASE2CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Kidney Disease
Interventions
DRUG

1278863A

25mg, 50mg, 100mg

DRUG

Placebo

matching placebo

Trial Locations (37)

1150

GSK Investigational Site, Auckland

2050

GSK Investigational Site, Camperdown

2065

GSK Investigational Site, St Leonards

2250

GSK Investigational Site, Gosford

3073

GSK Investigational Site, Reservoir

3128

GSK Investigational Site, Box Hill

4029

GSK Investigational Site, Herston

8140

GSK Investigational Site, Christchurch

109240

GSK Investigational Site, Moscow

109472

GSK Investigational Site, Moscow

115093

GSK Investigational Site, Moscow

119021

GSK Investigational Site, Moscow

119620

GSK Investigational Site, Moscow

123183

GSK Investigational Site, Moscow

125101

GSK Investigational Site, Moscow

150062

GSK Investigational Site, Yaroslavl

191015

GSK Investigational Site, Saint Petersburg

191104

GSK Investigational Site, Saint Petersburg

191186

GSK Investigational Site, Saint Petersburg

195067

GSK Investigational Site, Saint Petersburg

196247

GSK Investigational Site, Saint Petersburg

197022

GSK Investigational Site, Saint Petersburg

197110

GSK Investigational Site, Saint Petersburg

214006

GSK Investigational Site, Smolensk

400008

GSK Investigational Site, Mumbai

404120

GSK Investigational Site, Volzhsky

410053

GSK Investigational Site, Saratov

500012

GSK Investigational Site, Hyderabad

530002

GSK Investigational Site, Visakhapatnam

560004

GSK Investigational Site, Bangalore

560017

GSK Investigational Site, Bangalore

603032

GSK Investigational Site, Nizhny Novgorod

605014

GSK Investigational Site, Kalapet Pondicherry

614097

GSK Investigational Site, Perm

620102

GSK Investigational Site, Yekaterinburg

5000068

GSK Investigational Site, Hyderabad

Unknown

GSK Investigational Site, New Delhi

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01047397 - Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia | Biotech Hunter | Biotech Hunter